Relypsa Inc (RLYP) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 CARDINAL WAY
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2016
MRQ
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 240,716,000135,757,000
Cash and cash equivalents 63,723,00030,264,000
Short-term investments 176,993,000105,493,000
Restricted cash and investments  268,000
Receivables 1,309,000425,000
Inventory, net of allowances, customer advances and progress billings 8,851,000 
Inventory 8,851,000 
Other undisclosed current assets 5,405,0002,756,000
Total current assets: 256,281,000139,206,000
Noncurrent Assets
Property, plant and equipment 9,627,0003,467,000
Restricted cash and investments 1,436,000686,000
Other noncurrent assets 10,984,0008,480,000
Total noncurrent assets: 22,047,00012,633,000
TOTAL ASSETS: 278,328,000151,839,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 52,609,00015,327,000
Employee-related liabilities 11,835,0004,393,000
Accounts payable 3,037,0003,156,000
Accrued liabilities 37,737,0007,778,000
Debt 301,000432,000
Deferred revenue and credits 16,269,0001,156,000
Total current liabilities: 69,179,00016,915,000
Noncurrent Liabilities
Long-term debt and lease obligation 15,592,00015,213,000
Long-term debt, excluding current maturities 15,592,00015,213,000
Liabilities, other than long-term debt 8,684,0006,583,000
Deferred revenue and credits 8,684,000983,000
Liability for uncertainty in income taxes  5,600,000
Other undisclosed noncurrent liabilities  (5,333,000)
Total noncurrent liabilities: 24,276,00016,463,000
Total liabilities: 93,455,00033,378,000
Equity
Equity, attributable to parent 184,873,000118,461,000
Common stock 42,00035,000
Additional paid in capital 669,331,000424,175,000
Accumulated other comprehensive loss (56,000)(21,000)
Accumulated deficit (484,444,000)(305,728,000)
Total equity: 184,873,000118,461,000
TOTAL LIABILITIES AND EQUITY: 278,328,000151,839,000

Income Statement (P&L) (USD)

6/30/2016
TTM
12/31/2015
12/31/2014
Operating expenses (196,436,000)(78,141,000)
Other undisclosed operating income 18,550,000 
Operating loss: (177,886,000)(78,141,000)
Nonoperating income 915,000149,000
Investment income, nonoperating (1,314,000) 
Interest and debt expense (1,745,000)(1,896,000)
Loss from continuing operations: (178,716,000)(79,888,000)
Loss before gain (loss) on sale of properties: (178,716,000)(79,888,000)
Net loss available to common stockholders, diluted: (178,716,000)(79,888,000)

Comprehensive Income (USD)

6/30/2016
TTM
12/31/2015
12/31/2014
Net loss: (178,716,000)(79,888,000)
Comprehensive loss: (178,716,000)(79,888,000)
Other undisclosed comprehensive loss, net of tax, attributable to parent (35,000)(21,000)
Comprehensive loss, net of tax, attributable to parent: (178,751,000)(79,909,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: